Shionogi & Co., Ltd.
Shionogi & Co., Ltd. SGIOY Peers
See (SGIOY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SGIOY | $8.40 | +0.12% | 14.3B | 12.00 | $0.70 | +0.84% |
| MKGAF | $133.94 | +0.89% | 58.2B | 18.20 | $7.36 | +1.62% |
| MKKGY | $26.44 | +0.48% | 57.8B | 17.99 | $1.47 | +2.17% |
| HLNCF | $5.63 | -0.18% | 50.8B | 26.81 | $0.21 | +1.93% |
| TKPHF | $27.60 | -1.53% | 43.4B | 58.72 | $0.47 | +4.82% |
| IPSEY | $30.32 | +1.25% | 40.1B | 24.85 | $1.22 | N/A |
| SDZNY | $53.51 | +0.07% | 23B | -2675.25 | -$0.02 | +1.27% |
| TEVJF | $17.80 | N/A | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $16.45 | +8.22% | 14B | 11.67 | $1.41 | +2.74% |
Stock Comparison
SGIOY vs MKGAF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, MKGAF has a market cap of 58.2B. Regarding current trading prices, SGIOY is priced at $8.40, while MKGAF trades at $133.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas MKGAF's P/E ratio is 18.20. In terms of profitability, SGIOY's ROE is +0.08%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, SGIOY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs MKKGY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, MKKGY has a market cap of 57.8B. Regarding current trading prices, SGIOY is priced at $8.40, while MKKGY trades at $26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas MKKGY's P/E ratio is 17.99. In terms of profitability, SGIOY's ROE is +0.08%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, SGIOY is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HLNCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HLNCF has a market cap of 50.8B. Regarding current trading prices, SGIOY is priced at $8.40, while HLNCF trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HLNCF's P/E ratio is 26.81. In terms of profitability, SGIOY's ROE is +0.08%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, SGIOY is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TKPHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TKPHF has a market cap of 43.4B. Regarding current trading prices, SGIOY is priced at $8.40, while TKPHF trades at $27.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TKPHF's P/E ratio is 58.72. In terms of profitability, SGIOY's ROE is +0.08%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, SGIOY is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs IPSEY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, IPSEY has a market cap of 40.1B. Regarding current trading prices, SGIOY is priced at $8.40, while IPSEY trades at $30.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas IPSEY's P/E ratio is 24.85. In terms of profitability, SGIOY's ROE is +0.08%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, SGIOY is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SDZNY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SDZNY has a market cap of 23B. Regarding current trading prices, SGIOY is priced at $8.40, while SDZNY trades at $53.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SDZNY's P/E ratio is -2675.25. In terms of profitability, SGIOY's ROE is +0.08%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, SGIOY is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TEVJF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, SGIOY is priced at $8.40, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, SGIOY's ROE is +0.08%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, SGIOY is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ESALY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, SGIOY is priced at $8.40, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ESALY's P/E ratio is 20.54. In terms of profitability, SGIOY's ROE is +0.08%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, SGIOY is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SGIOF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SGIOF has a market cap of 14B. Regarding current trading prices, SGIOY is priced at $8.40, while SGIOF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SGIOF's P/E ratio is 11.67. In terms of profitability, SGIOY's ROE is +0.08%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, SGIOY is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs BIOVF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, BIOVF has a market cap of 10.4B. Regarding current trading prices, SGIOY is priced at $8.40, while BIOVF trades at $30.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas BIOVF's P/E ratio is 25.45. In terms of profitability, SGIOY's ROE is +0.08%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, SGIOY is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs IPSEF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, SGIOY is priced at $8.40, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas IPSEF's P/E ratio is 26.17. In terms of profitability, SGIOY's ROE is +0.08%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, SGIOY is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SFOSF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SFOSF has a market cap of 8.5B. Regarding current trading prices, SGIOY is priced at $8.40, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, SGIOY's ROE is +0.08%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, SGIOY is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ESAIY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ESAIY has a market cap of 7.8B. Regarding current trading prices, SGIOY is priced at $8.40, while ESAIY trades at $6.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ESAIY's P/E ratio is 24.18. In terms of profitability, SGIOY's ROE is +0.08%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, SGIOY is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ESALF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ESALF has a market cap of 7.1B. Regarding current trading prices, SGIOY is priced at $8.40, while ESALF trades at $25.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ESALF's P/E ratio is 22.16. In terms of profitability, SGIOY's ROE is +0.08%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, SGIOY is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HKMPY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, SGIOY is priced at $8.40, while HKMPY trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HKMPY's P/E ratio is 17.67. In terms of profitability, SGIOY's ROE is +0.08%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, SGIOY is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HKMPF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, SGIOY is priced at $8.40, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, SGIOY's ROE is +0.08%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, SGIOY is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs GZPHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, SGIOY is priced at $8.40, while GZPHF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas GZPHF's P/E ratio is 9.57. In terms of profitability, SGIOY's ROE is +0.08%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, SGIOY is less volatile compared to GZPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs APNHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, APNHF has a market cap of 5.4B. Regarding current trading prices, SGIOY is priced at $8.40, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas APNHF's P/E ratio is 20.07. In terms of profitability, SGIOY's ROE is +0.08%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, SGIOY is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs WIBFF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, SGIOY is priced at $8.40, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, SGIOY's ROE is +0.08%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, SGIOY is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HLBBF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, SGIOY is priced at $8.40, while HLBBF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HLBBF's P/E ratio is 11.71. In terms of profitability, SGIOY's ROE is +0.08%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, SGIOY is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LVZPF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LVZPF has a market cap of 3.9B. Regarding current trading prices, SGIOY is priced at $8.40, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, SGIOY's ROE is +0.08%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, SGIOY is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HLUBF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HLUBF has a market cap of 3.5B. Regarding current trading prices, SGIOY is priced at $8.40, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HLUBF's P/E ratio is 7.55. In terms of profitability, SGIOY's ROE is +0.08%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, SGIOY is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs APNHY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, APNHY has a market cap of 3.1B. Regarding current trading prices, SGIOY is priced at $8.40, while APNHY trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas APNHY's P/E ratio is 12.27. In terms of profitability, SGIOY's ROE is +0.08%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, SGIOY is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs INVVY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, SGIOY is priced at $8.40, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas INVVY's P/E ratio is -62.42. In terms of profitability, SGIOY's ROE is +0.08%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, SGIOY is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HYPMY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HYPMY has a market cap of 3B. Regarding current trading prices, SGIOY is priced at $8.40, while HYPMY trades at $4.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HYPMY's P/E ratio is 21.23. In terms of profitability, SGIOY's ROE is +0.08%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, SGIOY is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs IZQVF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, SGIOY is priced at $8.40, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, SGIOY's ROE is +0.08%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, SGIOY is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HMDCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, SGIOY is priced at $8.40, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, SGIOY's ROE is +0.08%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, SGIOY is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs DNPUF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, SGIOY is priced at $8.40, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas DNPUF's P/E ratio is 15.93. In terms of profitability, SGIOY's ROE is +0.08%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, SGIOY is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ULIHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, SGIOY is priced at $8.40, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, SGIOY is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs THCBF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, SGIOY is priced at $8.40, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas THCBF's P/E ratio is -0.10. In terms of profitability, SGIOY's ROE is +0.08%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, SGIOY is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HTSUF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, SGIOY is priced at $8.40, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HTSUF's P/E ratio is 15.76. In terms of profitability, SGIOY's ROE is +0.08%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, SGIOY is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CHSYF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, SGIOY is priced at $8.40, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, SGIOY's ROE is +0.08%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, SGIOY is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TSMRF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, SGIOY is priced at $8.40, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, SGIOY's ROE is +0.08%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, SGIOY is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs DMPHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, SGIOY is priced at $8.40, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas DMPHF's P/E ratio is 18.15. In terms of profitability, SGIOY's ROE is +0.08%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, SGIOY is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LJUIF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, SGIOY is priced at $8.40, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, SGIOY's ROE is +0.08%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, SGIOY is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LBTSF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LBTSF has a market cap of 1.9B. Regarding current trading prices, SGIOY is priced at $8.40, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, SGIOY's ROE is +0.08%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, SGIOY is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs NPNKF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, SGIOY is priced at $8.40, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas NPNKF's P/E ratio is 7.55. In terms of profitability, SGIOY's ROE is +0.08%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, SGIOY is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs NPPNY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, SGIOY is priced at $8.40, while NPPNY trades at $6.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas NPPNY's P/E ratio is 7.22. In terms of profitability, SGIOY's ROE is +0.08%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, SGIOY is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SMDPY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, SGIOY is priced at $8.40, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SMDPY's P/E ratio is 9.76. In terms of profitability, SGIOY's ROE is +0.08%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, SGIOY is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SHEZF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SHEZF has a market cap of 1.6B. Regarding current trading prices, SGIOY is priced at $8.40, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, SGIOY's ROE is +0.08%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, SGIOY is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs MITPF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, SGIOY is priced at $8.40, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas MITPF's P/E ratio is -10.81. In terms of profitability, SGIOY's ROE is +0.08%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, SGIOY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs YIHCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, SGIOY is priced at $8.40, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, SGIOY is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs KARBF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, SGIOY is priced at $8.40, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas KARBF's P/E ratio is 262.50. In terms of profitability, SGIOY's ROE is +0.08%, compared to KARBF's ROE of N/A. Regarding short-term risk, SGIOY is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs EVOTF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, SGIOY is priced at $8.40, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, SGIOY's ROE is +0.08%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, SGIOY is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ARSUF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ARSUF has a market cap of 1.5B. Regarding current trading prices, SGIOY is priced at $8.40, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, SGIOY's ROE is +0.08%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, SGIOY is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs GTBIF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, SGIOY is priced at $8.40, while GTBIF trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas GTBIF's P/E ratio is 24.62. In terms of profitability, SGIOY's ROE is +0.08%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, SGIOY is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CHIZF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CHIZF has a market cap of 1.2B. Regarding current trading prices, SGIOY is priced at $8.40, while CHIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CHIZF's P/E ratio is 12.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, SGIOY is less volatile compared to CHIZF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs KSPHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, SGIOY is priced at $8.40, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas KSPHF's P/E ratio is 14.20. In terms of profitability, SGIOY's ROE is +0.08%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, SGIOY is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SWGHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, SGIOY is priced at $8.40, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, SGIOY's ROE is +0.08%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, SGIOY is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs GNMLF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, SGIOY is priced at $8.40, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas GNMLF's P/E ratio is 10.36. In terms of profitability, SGIOY's ROE is +0.08%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, SGIOY is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs KKPCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, SGIOY is priced at $8.40, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas KKPCF's P/E ratio is 10.46. In terms of profitability, SGIOY's ROE is +0.08%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, SGIOY is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CASBF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CASBF has a market cap of 1B. Regarding current trading prices, SGIOY is priced at $8.40, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CASBF's P/E ratio is -15.24. In terms of profitability, SGIOY's ROE is +0.08%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, SGIOY is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SHPHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, SGIOY is priced at $8.40, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, SGIOY's ROE is +0.08%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, SGIOY is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LVTTF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LVTTF has a market cap of 894.3M. Regarding current trading prices, SGIOY is priced at $8.40, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, SGIOY's ROE is +0.08%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, SGIOY is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs EVRRF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, EVRRF has a market cap of 893.7M. Regarding current trading prices, SGIOY is priced at $8.40, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, SGIOY's ROE is +0.08%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, SGIOY is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs BIOGY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, SGIOY is priced at $8.40, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, SGIOY's ROE is +0.08%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, SGIOY is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs NRXCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, NRXCF has a market cap of 844.9M. Regarding current trading prices, SGIOY is priced at $8.40, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, SGIOY's ROE is +0.08%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, SGIOY is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TWAPF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, SGIOY is priced at $8.40, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, SGIOY's ROE is +0.08%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, SGIOY is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CSWYF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, SGIOY is priced at $8.40, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, SGIOY's ROE is +0.08%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, SGIOY is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TCNNF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TCNNF has a market cap of 754M. Regarding current trading prices, SGIOY is priced at $8.40, while TCNNF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TCNNF's P/E ratio is -4.99. In terms of profitability, SGIOY's ROE is +0.08%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, SGIOY is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TRXPF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, SGIOY is priced at $8.40, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, SGIOY's ROE is +0.08%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, SGIOY is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SWDCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, SGIOY is priced at $8.40, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, SGIOY's ROE is +0.08%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, SGIOY is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs NIKA Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, NIKA has a market cap of 666.7M. Regarding current trading prices, SGIOY is priced at $8.40, while NIKA trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas NIKA's P/E ratio is N/A. In terms of profitability, SGIOY's ROE is +0.08%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, SGIOY is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CURLF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CURLF has a market cap of 659M. Regarding current trading prices, SGIOY is priced at $8.40, while CURLF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CURLF's P/E ratio is -2.64. In terms of profitability, SGIOY's ROE is +0.08%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, SGIOY is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ELTP Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ELTP has a market cap of 628.8M. Regarding current trading prices, SGIOY is priced at $8.40, while ELTP trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ELTP's P/E ratio is -29.43. In terms of profitability, SGIOY's ROE is +0.08%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, SGIOY is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs TRSSF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, SGIOY is priced at $8.40, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, SGIOY's ROE is +0.08%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, SGIOY is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CCHWF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, SGIOY is priced at $8.40, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, SGIOY's ROE is +0.08%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, SGIOY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs SGFEF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, SGFEF has a market cap of 508.7M. Regarding current trading prices, SGIOY is priced at $8.40, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas SGFEF's P/E ratio is 22.88. In terms of profitability, SGIOY's ROE is +0.08%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, SGIOY is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs AIHLF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, SGIOY is priced at $8.40, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, SGIOY's ROE is +0.08%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, SGIOY is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs BOIRF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, SGIOY is priced at $8.40, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, SGIOY's ROE is +0.08%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, SGIOY is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs PEXXF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, SGIOY is priced at $8.40, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to PEXXF's ROE of N/A. Regarding short-term risk, SGIOY is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs KHTRF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, KHTRF has a market cap of 439.2M. Regarding current trading prices, SGIOY is priced at $8.40, while KHTRF trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas KHTRF's P/E ratio is 62.98. In terms of profitability, SGIOY's ROE is +0.08%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, SGIOY is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs AGYTF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, SGIOY is priced at $8.40, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, SGIOY's ROE is +0.08%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, SGIOY is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs GLASF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, GLASF has a market cap of 299.5M. Regarding current trading prices, SGIOY is priced at $8.40, while GLASF trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas GLASF's P/E ratio is -63.67. In terms of profitability, SGIOY's ROE is +0.08%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, SGIOY is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs PKBFF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, PKBFF has a market cap of 289.4M. Regarding current trading prices, SGIOY is priced at $8.40, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, SGIOY is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs BHCCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, SGIOY is priced at $8.40, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, SGIOY's ROE is +0.08%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, SGIOY is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CPHRF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CPHRF has a market cap of 247M. Regarding current trading prices, SGIOY is priced at $8.40, while CPHRF trades at $9.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CPHRF's P/E ratio is 27.54. In terms of profitability, SGIOY's ROE is +0.08%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, SGIOY is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CRLBF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CRLBF has a market cap of 243.6M. Regarding current trading prices, SGIOY is priced at $8.40, while CRLBF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CRLBF's P/E ratio is -2.28. In terms of profitability, SGIOY's ROE is +0.08%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, SGIOY is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs PLNHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, SGIOY is priced at $8.40, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, SGIOY's ROE is +0.08%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, SGIOY is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs VRNOF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, VRNOF has a market cap of 196M. Regarding current trading prices, SGIOY is priced at $8.40, while VRNOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas VRNOF's P/E ratio is -0.55. In terms of profitability, SGIOY's ROE is +0.08%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, SGIOY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HUMDF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, SGIOY is priced at $8.40, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, SGIOY's ROE is +0.08%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, SGIOY is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs DUTV Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, DUTV has a market cap of 145.1M. Regarding current trading prices, SGIOY is priced at $8.40, while DUTV trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas DUTV's P/E ratio is N/A. In terms of profitability, SGIOY's ROE is +0.08%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, SGIOY is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs PHCUF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, PHCUF has a market cap of 133.5M. Regarding current trading prices, SGIOY is priced at $8.40, while PHCUF trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas PHCUF's P/E ratio is 501.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, SGIOY is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs COPHF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, SGIOY is priced at $8.40, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas COPHF's P/E ratio is -0.02. In terms of profitability, SGIOY's ROE is +0.08%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, SGIOY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs STMH Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, STMH has a market cap of 126.5M. Regarding current trading prices, SGIOY is priced at $8.40, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas STMH's P/E ratio is N/A. In terms of profitability, SGIOY's ROE is +0.08%, compared to STMH's ROE of -2.75%. Regarding short-term risk, SGIOY is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs HLTRF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, HLTRF has a market cap of 115.8M. Regarding current trading prices, SGIOY is priced at $8.40, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas HLTRF's P/E ratio is -5.63. In terms of profitability, SGIOY's ROE is +0.08%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, SGIOY is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LPCUF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, SGIOY is priced at $8.40, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, SGIOY's ROE is +0.08%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, SGIOY is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CNVCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, SGIOY is priced at $8.40, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, SGIOY is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs BIOYF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, BIOYF has a market cap of 97.8M. Regarding current trading prices, SGIOY is priced at $8.40, while BIOYF trades at $8.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas BIOYF's P/E ratio is 17.41. In terms of profitability, SGIOY's ROE is +0.08%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, SGIOY is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs GRUSF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, GRUSF has a market cap of 86.7M. Regarding current trading prices, SGIOY is priced at $8.40, while GRUSF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas GRUSF's P/E ratio is -7.00. In terms of profitability, SGIOY's ROE is +0.08%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, SGIOY is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LRDSF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, SGIOY is priced at $8.40, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, SGIOY's ROE is +0.08%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, SGIOY is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs GBLP Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, SGIOY is priced at $8.40, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas GBLP's P/E ratio is -0.67. In terms of profitability, SGIOY's ROE is +0.08%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, SGIOY is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs LOVFF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, LOVFF has a market cap of 80.9M. Regarding current trading prices, SGIOY is priced at $8.40, while LOVFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas LOVFF's P/E ratio is 8.85. In terms of profitability, SGIOY's ROE is +0.08%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, SGIOY is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ABSCF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ABSCF has a market cap of 74.8M. Regarding current trading prices, SGIOY is priced at $8.40, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, SGIOY's ROE is +0.08%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, SGIOY is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs EOFBY Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, SGIOY is priced at $8.40, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, SGIOY's ROE is +0.08%, compared to EOFBY's ROE of N/A. Regarding short-term risk, SGIOY is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs CBWTF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, CBWTF has a market cap of 73.7M. Regarding current trading prices, SGIOY is priced at $8.40, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas CBWTF's P/E ratio is 2.80. In terms of profitability, SGIOY's ROE is +0.08%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, SGIOY is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs MEDXF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, MEDXF has a market cap of 69M. Regarding current trading prices, SGIOY is priced at $8.40, while MEDXF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas MEDXF's P/E ratio is 14.27. In terms of profitability, SGIOY's ROE is +0.08%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, SGIOY is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs ORXOF Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, ORXOF has a market cap of 65.6M. Regarding current trading prices, SGIOY is priced at $8.40, while ORXOF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas ORXOF's P/E ratio is -6.79. In terms of profitability, SGIOY's ROE is +0.08%, compared to ORXOF's ROE of +2.89%. Regarding short-term risk, SGIOY is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for SGIOY.
SGIOY vs AAWH Comparison
SGIOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGIOY stands at 14.3B. In comparison, AAWH has a market cap of 65.4M. Regarding current trading prices, SGIOY is priced at $8.40, while AAWH trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGIOY currently has a P/E ratio of 12.00, whereas AAWH's P/E ratio is -0.80. In terms of profitability, SGIOY's ROE is +0.08%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, SGIOY is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for SGIOY.